Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells
Open Access
- 1 January 1986
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 87 (1) , 233-242
- https://doi.org/10.1111/j.1476-5381.1986.tb10176.x
Abstract
1 Adenosine produced a concentration-related enhancement of antigen-induced 5-hydroxytryptamine (5-HT) release from rat serosal mast cells. This potentiation was maximal following the simultaneous addition of adenosine with antigen. 2 Enhancement of 5-HT release was accompanied by potentiation of the adenosine 3′:5′-cyclic monophosphate (cyclic AMP) response to challenge. The cyclic AMP response, which was antagonized by 8-phenyltheophylline, was characterized as an A2-purinoceptor-mediated effect by the use of 5′-N-ethylcarboxamideadenosine (NECA) and L-N6-phenylisopropyladenosine (L-PIA). 3 Enhancement of 5-HT release, conversely, was not blocked by 8-phenyltheophylline suggesting it to be mediated by a cyclic AMP-independent mechanism. 4 The effect of adenosine on 5-HT release was not reduced by the inhibition of the facilitated uptake of adenosine with dipyridamole, hexobendine or p-nitrobenzylthioguanosine, therefore, suggesting it to be mediated by a cell surface receptor. 5 The receptor mediating enhancement of 5-HT does not appear to belong to the P2-purinoceptor subtype as adenosine was more potent than both adenosine monophosphate (AMP) and adenosine diphosphate (ADP) and α,β-methylene ATP was inactive. Furthermore, the effects of AMP were blocked by α,β-methylene ADP, which inhibits the conversion of AMP to adenosine. 6 Adenosine, NECA, L- and D-PIA were all of equal potency in enhancing 5-HT release. Inosine and 3-deazaadenosine were also active. The rank order of potency of these adenosine analogues is not consistent with an effect at A1- or A2-purinoceptors. 7 There appear to be two adenosine receptors on rat mast cells, an A2-purinoceptor which stimulates adenylate cyclase and a separate purinoceptor, stimulation of which produces enhancement of mediator release by an unknown mechanism. The effects mediated by these receptors appear to be independent of each other.This publication has 31 references indexed in Scilit:
- Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesteraseNature, 1985
- Role of cyclic AMP in the induction of histamine secretion from mast cellsInflammation Research, 1985
- Involvement of guanine nucleotide-binding protein in the gating of Ca2+ by receptorsNature, 1983
- The relationship between cyclic amp changes and histamine release from basophil-rich human leucocytesBiochemical Pharmacology, 1983
- Adenosine receptors: targets for future drugsJournal of Medicinal Chemistry, 1982
- Inhibitors of adenosine deaminasePharmacology & Therapeutics, 1982
- 8-Phenyltheophylline: A potent P1-purinoceptor antagonistEuropean Journal of Pharmacology, 1981
- Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonistsCanadian Journal of Physiology and Pharmacology, 1980
- ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLSJournal of Neurochemistry, 1979
- The Influence of Adenosine Triphosphate on Isolated Rat Peritoneal Mast CellsInternational Archives of Allergy and Immunology, 1969